CA Stock MarketDetailed Quotes

VM Voyageur Pharmaceuticals Ltd

Watchlist
  • 0.075
  • +0.005+7.14%
15min DelayTrading Oct 18 09:30 ET
10.46MMarket Cap-7500P/E (TTM)

Voyageur Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-9.59%561.9K
-11.97%328.95K
-23.15%1.35M
-59.98%229.24K
-69.38%130.69K
30.42%621.49K
51.08%373.69K
-14.46%1.75M
11.32%572.81K
15.64%426.82K
Selling and administrative expenses
-1.53%404.54K
19.09%279.06K
-12.52%940.01K
-38.17%231.46K
-72.27%72.13K
24.70%410.84K
132.10%234.31K
-27.01%1.07M
12.71%374.35K
44.18%260.12K
-General and administrative expense
-1.53%404.54K
19.09%279.06K
-12.52%940.01K
-38.17%231.46K
-72.27%72.13K
24.70%410.84K
132.10%234.31K
-27.01%1.07M
12.71%374.35K
44.18%260.12K
Research and development costs
-36.83%104.82K
-85.53%12.63K
-46.75%280.94K
-109.74%-9.37K
-73.75%37.07K
19.91%165.95K
-39.88%87.29K
6.25%527.56K
-39.00%96.15K
-15.32%141.19K
Depreciation amortization depletion
-28.02%393
-28.02%393
-24.86%2.19K
-24.90%546
-24.90%546
-24.90%546
-24.90%546
29.47%2.91K
-67.63%727
--727
-Depreciation and amortization
-28.02%393
-28.02%393
-24.86%2.19K
-24.90%546
-24.90%546
-24.90%546
-24.90%546
29.47%2.91K
-67.63%727
--727
Other operating expenses
18.10%52.15K
-28.47%36.87K
-16.11%123.24K
-93.50%6.6K
-15.50%20.94K
455.85%44.16K
10,614.97%51.54K
90.26%146.91K
350.47%101.58K
13.03%24.79K
Operating profit
9.59%-561.9K
11.97%-328.95K
23.15%-1.35M
59.98%-229.24K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.46%-1.75M
-11.32%-572.81K
-15.64%-426.82K
Net non-operating interest income (expenses)
-4.48K
0
Non-operating interest expense
----
----
--4.48K
----
----
----
----
--0
----
----
Other net income (expenses)
-2,368.77%-48.61K
-1.97K
Special income (charges)
----
--0
-2,368.77%-48.61K
----
----
----
----
---1.97K
----
----
-Less:Impairment of capital assets
----
--0
--48.61K
----
----
----
----
--0
----
----
-Less:Other special charges
----
----
----
----
----
----
----
---4.24K
----
----
-Gain on sale of property,plant,equipment
----
----
--0
----
----
----
----
---6.21K
----
----
Income before tax
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
-15.64%-426.82K
Income tax
Earnings from equity interest net of tax
Net income
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
-15.64%-426.82K
Net income continuous operations
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
-15.64%-426.82K
Noncontrolling interests
Net income attributable to the company
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
-15.64%-426.82K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
-15.64%-426.82K
Diluted earnings per share
13.60%-0.004
17.92%-0.0025
50.00%-0.01
0
73.56%-0.001
-0.26%-0.0047
-24.60%-0.003
0.00%-0.02
-0.01
10.24%-0.0037
Basic earnings per share
13.60%-0.004
17.92%-0.0025
50.00%-0.01
0
73.56%-0.001
-0.26%-0.0047
-24.60%-0.003
0.00%-0.02
-0.01
10.24%-0.0037
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -9.59%561.9K-11.97%328.95K-23.15%1.35M-59.98%229.24K-69.38%130.69K30.42%621.49K51.08%373.69K-14.46%1.75M11.32%572.81K15.64%426.82K
Selling and administrative expenses -1.53%404.54K19.09%279.06K-12.52%940.01K-38.17%231.46K-72.27%72.13K24.70%410.84K132.10%234.31K-27.01%1.07M12.71%374.35K44.18%260.12K
-General and administrative expense -1.53%404.54K19.09%279.06K-12.52%940.01K-38.17%231.46K-72.27%72.13K24.70%410.84K132.10%234.31K-27.01%1.07M12.71%374.35K44.18%260.12K
Research and development costs -36.83%104.82K-85.53%12.63K-46.75%280.94K-109.74%-9.37K-73.75%37.07K19.91%165.95K-39.88%87.29K6.25%527.56K-39.00%96.15K-15.32%141.19K
Depreciation amortization depletion -28.02%393-28.02%393-24.86%2.19K-24.90%546-24.90%546-24.90%546-24.90%54629.47%2.91K-67.63%727--727
-Depreciation and amortization -28.02%393-28.02%393-24.86%2.19K-24.90%546-24.90%546-24.90%546-24.90%54629.47%2.91K-67.63%727--727
Other operating expenses 18.10%52.15K-28.47%36.87K-16.11%123.24K-93.50%6.6K-15.50%20.94K455.85%44.16K10,614.97%51.54K90.26%146.91K350.47%101.58K13.03%24.79K
Operating profit 9.59%-561.9K11.97%-328.95K23.15%-1.35M59.98%-229.24K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.46%-1.75M-11.32%-572.81K-15.64%-426.82K
Net non-operating interest income (expenses) -4.48K0
Non-operating interest expense ----------4.48K------------------0--------
Other net income (expenses) -2,368.77%-48.61K-1.97K
Special income (charges) ------0-2,368.77%-48.61K-------------------1.97K--------
-Less:Impairment of capital assets ------0--48.61K------------------0--------
-Less:Other special charges -------------------------------4.24K--------
-Gain on sale of property,plant,equipment ----------0-------------------6.21K--------
Income before tax 9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K-15.64%-426.82K
Income tax
Earnings from equity interest net of tax
Net income 9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K-15.64%-426.82K
Net income continuous operations 9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K-15.64%-426.82K
Noncontrolling interests
Net income attributable to the company 9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K-15.64%-426.82K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K-15.64%-426.82K
Diluted earnings per share 13.60%-0.00417.92%-0.002550.00%-0.01073.56%-0.001-0.26%-0.0047-24.60%-0.0030.00%-0.02-0.0110.24%-0.0037
Basic earnings per share 13.60%-0.00417.92%-0.002550.00%-0.01073.56%-0.001-0.26%-0.0047-24.60%-0.0030.00%-0.02-0.0110.24%-0.0037
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data